Delivery Order SPE2DB22D2206-SPE2DB25FDQ02
Award Date
10/4/24
Potential Completion Date
10/28/24
Potential Value
$31K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IBRANCE 100 MG CAPSULE 21S. The $23,388.90 fixed-price contract has an ultimate completion date of August 27, 2024. AmerisourceBergen holds several large Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, which serve as primary vehicles for providing a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,796.30 contract is for the supply of IBRANCE 100 MG CAPSULE 21S, a specialty cancer medication. The award has an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for providing a wide range of...
This federal contract award is a delivery order valued at $8,123.96 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product, and has an ultimate completion date of April 11, 2025. The contract is an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, with a ceiling value of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,065.75 firm fixed-price delivery order is for the supply of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product, with a period of performance through February 12, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award, valued at $16,131.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product, with a completion date of February 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,185.24 firm fixed-price delivery order contract is for the supply of IBRANCE 100 MG CAPSULE 21S, a specialty medication. The contract has an ultimate completion date of November 8, 2024 and was awarded on October 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,484.74, is for the delivery of IBRANCE 125 MG CAPSULE 21S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 21, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $7,792.08 firm fixed-price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 2025. The IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,484.74, is for the delivery of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of December 18, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the supply of IBRANCE 125 MG CAPSULE 21S, a specialty pharmaceutical product. The award has a ceiling value of $7,792.08 and an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31,...